Concepedia

R J van Alphen

RJ

Statistics

Publications

4

Citations

1K

H-Index

4

Active since

1998

Affiliations

University Medical Center Utrecht(Current)

Rotterdam University of Applied Sciences

Utrecht University

The Netherlands Cancer Institute

R J van Alphen is an author at University Medical Center Utrecht specializing in oncology, chemotherapy, and medicine.

Publications per year

1998–2020

4

Publications

4

Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

Ron H.J. Mathijssen, R J van Alphen, Jaco J. Verweij et al. · PubMed · 2001 · 752 citations · Full text

, , +17

Irinotecan (CPT-11) metabolism and disposition in cancer patients.

Alex Sparreboom, M J de Jonge, Peter de Bruijn et al. · PubMed · 1998 · 115 citations · Full text

, , +16

Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group

Johannes J.M. Kwakman, Lieke H. J. Simkens, Johan M. van Rooijen et al. · Annals of Oncology · 2017 · 83 citations

, , +12

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

Suzanna J. Schraa, Karlijn L. van Rooijen, Dave E. W. van der Kruijssen et al. · BMC Cancer · 2020 · 59 citations · Full text

, , +17

1–4 of 4